Stay updated on ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.

Latest updates to the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No study data or page content was altered.SummaryDifference0.1%

- Check60 days agoChange DetectedPublication notes were updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoval of the government funding/operating status notice from the page. Core study information such as eligibility criteria, endpoints, and study results remains unchanged.SummaryDifference0.4%

- Check81 days agoChange DetectedNo additions or deletions were detected on the page. The study details and layout appear unchanged.SummaryDifference0.3%

Stay in the know with updates to ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.